Bernard Shepard, Global Head - IT Infrastructure & Operation, CSL Behring, on the potential of Big Data in the pharmaceutical industry | Straight Talk

Bernard Shepard, Global Head - IT Infrastructure & Operation, CSL Behring, on the potential of Big Data in the pharmaceutical industry

Bernard Shepard
Head - Global IT Infrastructure & Operations
CSL Behring

IT Executive with 20+ years’ experience leading all aspects of information technology and delivering solutions that drive business efficiencies. Bernard has a strong track record directing strategic/technical program and project initiatives to maximize service performance and scalability across a global enterprise. He has a proven ability to leverage relationships and emerging technologies in order to streamline and enhance business operations and IT service delivery.

 

In this interview, Bernard discusses:

 

  • Automation as part of CSL’s transformation strategy

  • Business opportunities created by Big Data in the pharmaceutical industry

  • CSL’s policy on grooming future leaders

  • Role of IT in acquisitions

  • Technology predictions for the near future

 

About CSL Behring:

 

CSL Behring is part of the CSL Group, which has nearly 20,000 employees and does business in 60 countries. CSL Behring develops and delivers biotherapies for people with life-threatening medical conditions. CSL’s world-class commercial operation, combined with a large and focused R&D team and operational excellence, enables them to accurately identify, successfully develop, and dependably deliver innovations that patients and providers want. For a century, CSL Behring has earned a reputation as a passionate yet responsible organization, driven to care for patients and deliver on its commitments.